Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis

Are there concerns about generic medicines in rheumatology?

Licensing of antirheumatic drugs: are the EMA and FDA on the same page?

Irrelevance of the WHO analgesic ladder for managing rheumatic pain

Is there a role for anticonvulsants in the management of rheumatic pain?

Acetaminophen or NSAIDs for the treatment of osteoarthritis

Peptic ulcer disease in a patient with ankylosing spondylitis receiving a conventional nonsteroidal anti-inflammatory drug

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Antidepressants in rheumatic disorders: do they act as analgesics or antidepressants?

[Bone mineral density and bone metabolism in spondylarthropathies]

Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability

Emergency department visits caused by adverse drug events: results of a French survey

Drug-induced musculoskeletal disorders

Do selective cyclo-oxygenase-2 inhibitors have a future?

Gastrointestinal safety of paracetamol: is there any cause for concern?

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study

Prevalence of fibromyalgia: a survey in five European countries

Fibromyalgia syndrome in the general population of France: a prevalence study

Switching from originator infliximab to biosimilar CT-P13 in real-life: The weight of patient acceptance

Patients with Rheumatoid Arthritis in Remission While Receiving Etanercept Plus Methotrexate Therapy May Require Adjustment of Dosing Regimen When Switched to Methotrexate Monotherapy

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

Clinical safety of tocilizumab in rheumatoid arthritis

Comment on: Intravenous neridronate in the treatment of acute painful knee osteoarthritis: a randomized controlled study

Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2x2 factorial design

Efficacy of baricitinib in the treatment of rheumatoid arthritis

A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis

Nonspecific low back pain: assessment of available medications

A randomized, double-blind, placebo controlled triphosphate in study of oral adenosine subacute low back pain

Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability

Patients with Rheumatoid Arthritis in Remission While Receiving Etanercept Plus Methotrexate Therapy May Require Adjustment of Dosing Regimen When Switched to Methotrexate Monotherapy

[Admissions of elderly to French emergency departments related to adverse drug events]

Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study

Denosumab-induced severe hypocalcemia in a patient with Paget's disease of bone and impaired renal function